carbostyril has been researched along with Opportunistic Infections in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassi, AM; Mannini, A; Penco, S; Piatti, G; Saverino, D; Schito, AM | 1 |
| Grady, RW | 1 |
| Marchese, A; Roveta, S; Schito, AM; Schito, GC | 1 |
| Barza, M; Engels, EA; Lau, J | 1 |
| Bollet, C; de Lamballerie, X; de Micco, P; Gevaudan, MJ; Mallet, MN; Sambuc, R | 1 |
| Hughes, KL; Studdert, VP | 1 |
| Archambaud, M; Clavé, D; Massip, P; Moatti, N; Rouquet, RM | 1 |
| Bollet, C; de Micco, P; Gevaudan, MJ; Mallet, MN | 1 |
2 review(s) available for carbostyril and Opportunistic Infections
| Article | Year |
|---|---|
Systemic quinolone antibiotics in children: a review of the use and safety.
Topics: Age Factors; Anti-Bacterial Agents; Child; Child, Preschool; Humans; Immunocompromised Host; Infant; Infant, Newborn; Opportunistic Infections; Prospective Studies; Quinolones; Retrospective Studies; Safety; Urinary Tract Infections | 2005 |
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
Topics: Anti-Infective Agents; Antineoplastic Agents; Fever; Humans; Neoplasms; Neutropenia; Opportunistic Infections; Quinolones; Randomized Controlled Trials as Topic; Risk; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
7 other study(ies) available for carbostyril and Opportunistic Infections
| Article | Year |
|---|---|
Quinolone/fluoroquinolone susceptibility in Escherichia coli correlates with human polymicrobial bacteriuria and with in vitro interleukine-8 suppression.
Topics: Aged; Anti-Bacterial Agents; Bacteriuria; Epithelial Cells; Escherichia coli; Escherichia coli Infections; Female; Humans; Interleukin-8; Male; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Quinolones; Tumor Cells, Cultured; Urinary Bladder; Urinary Tract Infections | 2011 |
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cystic Fibrosis; Dioxolanes; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Opportunistic Infections; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Quinolones | 2005 |
[Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Mycobacterium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Opportunistic Infections; Quinolones; Rifabutin; Rifamycins | 1992 |
Treatment of opportunistic mycobacterial infections with enrofloxacin in cats.
Topics: Animals; Anti-Infective Agents; Cat Diseases; Cats; Enrofloxacin; Female; Fluoroquinolones; Male; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Quinolones; Skin Diseases, Infectious; Wound Infection | 1992 |
[In vitro activity of twenty antibiotics against Rhodococcus equi].
Topics: Actinomycetales Infections; Aminoglycosides; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Doxycycline; Drug Resistance, Microbial; HIV Infections; Humans; In Vitro Techniques; Lactams; Macrolides; Opportunistic Infections; Quinolones; Rhodococcus; Rifampin | 1991 |
[Activity of antibiotics against pigmented and unpigmented variants of Mycobacterium avium-intracellulare].
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Lactams, Macrocyclic; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Opportunistic Infections; Quinolones | 1991 |
Clinical results using two new antibiotics--clarithromycin and temafloxacin.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; Opportunistic Infections; Quinolones | 1991 |